Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma

• Main Authors: Zhenzhen Li (Author), Xin Li (Author), Xinyu He (Author), Xuechao Jia (Author), Xiaofan Zhang (Author), Bingbing Lu (Author), Jimin Zhao (Author), Jing Lu (Author), Lexia Chen (Author), Ziming Dong (Author), Kangdong Liu (Author), Zigang Dong (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

High recurrence rates and poor survival of patients with esophageal squamous cell carcinoma (ESCC) after treatment make ongoing research on chemoprevention drugs for ESCC particularly important. In this study, we screened a large number of FDA-approved drugs and found levodopa, a drug used to treat...